MHMd. Mofazzal Hossain

Md. Mofazzal Hossain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Md. Mofazzal Hossain has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the Therapeutic Potential of Metformin and Vitamin D 3 Combination in the Management of Diabetes Mellitus

    by Md. Ferdaus Azam, Md. Abu Bakar Siddique Jami, Nafis Yamin Suprio, Md. Ismail Kabir, Sabrina Tasnim Oishi, Jannatul Ferdous Ekra, Nusrat Islam, Samia Zaman, Md. Mofazzal Hossain, Md. Al Amin

    Background: Diabetes mellitus is a chronic metabolic disorder characterised by hyperglycaemia, dyslipidaemia, hepatic dysfunction, and loss of pancreatic β‐cells. Vitamin D 3 (D 3 ) may influence glucose and lipid metabolism and has been investigated for its potential complementary effects when administered with metformin (MT). In the present study, the anti‐diabetic activity of D 3 alone and when combined with MT was evaluated in Streptozotocin (STZ) induced diabetic mice. Methods: Swiss albino mice were made diabetic using STZ (45 mg/kg) injected intraperitoneally for 3 days. Diabetic mice were treated with MT (250 mg/kg), D 3 (100 μg/kg), or MT + D 3 for 21 days. The fasting blood glucose, serum lipid profile, body weight, alanine aminotransferase (ALT), and pancreatic histopathology were assessed. The data were analysed by ANOVA and Tukey's post hoc test, and a p ‐value < 0.05 was considered statistically significant. Results: The diabetic STZ mice showed sustained hyperglycaemia, weight loss, dyslipidaemia, increased ALT activity and degeneration of the islets of Langerhans. MT and D 3 treatments were associated with improvements in glycaemic control, and the combination treatment showed the greatest effect. Combined treatment was found to lower the level of total cholesterol (93.06 ± 2.89 mg/dL), LDL (28.66 mg/dL), triglycerides (120.33 ± 2.10 mg/dL) and ALT activity (52.60 ± 3.05 IU/L) and increase HDL (40.33 ± 2.10 mg/dL) when compared with diabetic controls. Moreover, the MT + D 3 group exhibited significant changes in the total cholesterol/HDL and LDL/HDL ratio and preserved the histoarchitecture of the pancreas. Conclusion: Metformin and vitamin D 3 , administered individually or in combination, were associated with improvements in several diabetes‐related metabolic parameters. The combination group showed greater observed metabolic outcomes than either treatment alone in STZ‐induced diabetic mice. Further adequately powered preclinical and clinical studies are required to determine the therapeutic relevance of this combination.


  • Open Access

    Preliminary Phytochemical Screening of Alternanthera bettzickiana (Regel) G. Nicholson Hydroethanolic Extract to Evaluate its Antioxidant, Anti-Inflammatory and Antimicrobial Properties

    by T. Islam, A. R. Chowdhury, M. Hossain, Z. A. Tareq

    This study aimed to assess the phytochemical composition and evaluate the antioxidant, anti-inflammatory, analgesic, and antimicrobial properties of the hydroethanolic extract derived from Alternanthera bettzickiana (Regel) G. Nicholson. Initial phytochemical screening revealed a diverse array of compounds in the crude extract, potentially contributing to its observed biological activities. The research employed various methodologies to investigate these properties. Antioxidant capacity was measured using hydrogen peroxide and DPPH radical scavenging assays, utilizing UV-Vis spectrophotometry. Anti-inflammatory activity was examined through an in vitro HRBC membrane stabilization method, comprising hemolytic and membrane stabilization experiments. Hemoglobin release from damaged erythrocyte membranes was quantified at 540 nm. Analgesic effects were assessed using the acetic acid-induced writhing test in mice, while antimicrobial activity was evaluated via the disc diffusion method, comparing plant extracts with standard treatments. The phytochemical analysis identified several key secondary metabolites in the extract, including phenols, tannins, saponins, volatile oils, proteins and amino acids, flavonoids, cholesterols, carboxylic acids, and lignins.While investigating the extract's antioxidant potential through DPPH (2,2-diphenyl-1-picryl-hydrazyl) and hydrogen peroxide scavenging assays, the researchers determined that the concentration required for 50% inhibition (IC50) varied significantly between the two methods, as the DPPH assay yielded an IC50 value of 229.6 µg/ml, whereas the hydrogen peroxide scavenging activity demonstrated a considerably lower IC50 value of 31.67 µg/ml. In the anti-inflammatory assay, the extract at 400 µg/ml exhibited 82.23% protection against RBC hemolysis, comparable to the 83.16% inhibition shown by diclofenac sodium at the same concentration. Analysis of the analgesic properties demonstrated that, while both diclofenac sodium and A. bettzickiana extract exhibited significant writhing inhibition (p ≤ 0.01) with values spanning from 35.44% to 87.76%, their efficacy differed notably as reflected in their IC50 values, where diclofenac sodium showed superior potency at 36.88 µg/ml compared to the A. bettzickiana extract's value of 101.39 µg/ml when tested against the control group. Antimicrobial testing showed that the plant extract was effective against B. megaterium (9 mm inhibition zone) and A. flavus (8 mm inhibition zone) out of six tested microorganisms. These findings suggest promising antioxidant, anti-inflammatory, antimicrobial, and analgesic (Pain-relief) effects of the A. bettzickiana hydroethanolic extract, as evidenced by both in vitro and in vivo observations.